Adult and pediatric relapsing multiple sclerosis phase II and phase III trial design and their primary end points: A systematic review
Article in Clinical and Translational Science (May 2024)
The most recent citing publications are shown below. View all 21 publications that cite this research output on Dimensions.
Immunopathogenesis of multiple sclerosis: molecular and cellular mechanisms and new immunotherapeutic approaches
Article in Immunopharmacology and Immunotoxicology (April 2024)
Adverse effects of immunotherapies for multiple sclerosis: a network meta‐analysis
Article in Cochrane Database of Systematic Reviews (November 2023)